Background: Fixed dose combinations are widely used in India, they are either irrational or prescribed irrationally. Moreover, the government has recently banned over 300 fixed dose combinations (FDCs) because of a lack of therapeutic justification. This study was conducted to study the prescribing pattern of FDCs in a tertiary care teaching hospital and to highlight the rationality of FDCs, and adverse drug reactions (ADRs) associated with them. Methods: In the present prospective observational study, a total of 500 inpatients were evaluated for prescribing pattern, cost analysis, and adverse drug reactions (ADRs) of FDCs. The FDCs were assessed for their rationality. The ADRs and severity were assessed using the WHO causality scale, Hartwig severity scale respectively. Results: Out of total 103 FDCs, 58 were approved, 86 were rational and 17 were irrational. 5 FDCs were banned and irrational. 48.54% of rational FDCs had rationality score from 7 to 9. The most commonly prescribed FDCs belonged to the anatomic therapeutic and chemical class of respiratory system, followed by anti-infectives in younger age group and cardiovascular FDCs in the elderly. The 886 ADRs occurred in 500 patients with a mean of 1.81±1.9. Banned FDCs contributed to 76 ADRs. According to causality and severity assessment, most of the ADRs were possible (62.53%) and mild (70.77%) respectively. Conclusions: Although FDCs were rational in most cases but banned FDCs were also prescribed. As these FDCs were associated with ADRs, monitoring of patients is necessary. Knowledge and attitude of healthcare professionals can be assessed through awareness programs.
INTRODUCTION
Fixed dose combination (FDC) is the combination of 2 or more active pharmaceutical ingredients (APIs) in a single dosage form designed to meet the requirements of the patient. It is an attempt to reduce the complexity of regimen in case of polypharmacy and enhance drug compliance; but they can cause interactions, adverse drug reactions (ADRs) or resistance (in case of antibiotics) when irrational or prescribed irrationally ultimately leading to increased healthcare cost. 1, 2 Not to forget, FDCs are being widely used in India and not all of them are rational. Irrational FDCs came in the market because companies take the license from State Licensing Authority (SLA) and SLA is under impression that FDC has been reviewed and necessary documents are checked and approved by the Central Licensing Authority (CLA), then SLA permits for import, manufacture, market or sale of FDC.
The possible reason for a wide range of FDCs in the Indian market is marketing interest and the fact that developing new chemical entity is difficult for a pharmaceutical company than to develop and market the FDC or fierce competition between manufacturers resulting in the products which don't have necessary therapeutic justification, safety, and efficacy. 3 While taking into account all the facts about FDCs, the Central Drugs Standard Control Organization had banned sales of 294 FDCs in 2007 but then companies and industry associations used legal means to push back government's order and now in 2018, once again the government has banned manufacture sale and distribution of over 300 FDCs due to lack of therapeutic justification. This study was conducted to evaluate the prescribing pattern, rationality of FDCs and ADRs caused by them if any in this tertiary care setting.
METHODS
A prospective observational study was carried out in the inpatient General Medicine Department of Bharati Hospital and Research Centre. A total of 500 patients were studied in 6 months (October 2018 to March 2019) for prescribing pattern of FDCs, their cost analysis and ADRs associated with them. The data was collected using a specially designed patient profile form and information regarding the presenting complaints, medical and medication history, medicines prescribed during hospitalization, laboratory investigations and daily notes were recorded to detect the possible ADRs. ADRs were assessed using the WHO causality scale and the Hartwig severity scale was used for assessment of severity of ADRs, the rationality of FDCs was assessed using a 7 point rationality assessment scale by Panda et al. 4 The study included all the inpatients that have been prescribed with at least 1 FDC. But pediatric patients were excluded from the study because it's difficult to prescribe an FDC in these patients due to difficulty in dividing the dose. Nutraceuticals were also excluded from the study because of the difficulty of their assessment. The data was collected, entered and assessed using Microsoft Excel 2007 and the results were recorded using descriptive statistics along with pivot tables.
RESULTS
Out of 500 inpatients, 261 were males and 239 were females. Age distribution of patients revealed that maximum patients belong to the age group of 48 to 57 years followed by 18 to 27 years and lastly age group of more than 78 years with an average age of patient being 47.58±17.94 years. 
URTI=upper respiratory infection, LRTI=lower respiratory tract infection, HTN=hypertension, DM= diabetes mellitus, IHD= ischemic heart disease.
A total of 307 drugs were prescribed to the patient with a mean of 7.47±2.66 drugs per patient. Out of 307 drugs, 103 (33.55%) were FDCs with the mean of 1.71±1.02 FDCs per patient. The most commonly prescribed FDCs belonged to the category of respiratory FDCs in all age groups except in 68 to 77 age group in which cardiovascular FDCs were commonly prescribed. The second most common class of FDCs was anti-infective and alimentary FDCs in younger age groups while cardiovascular and alimentary in the geriatric population. 
Age and diagnosis

Females Males
FDCs consumption was maximum in heart diseases like hypertension (32.66%) diabetes (28.90%) followed by lower respiratory tract infections (28.08%) and upper respiratory tract infections (7.52%) and lastly ischemic heart disease (1.98) and dengue (1.98%).
Oral dosage form (77%) was preferred over other dosage forms. Approximately 80% of the patients were prescribed with oral dosage forms. This is because the oral dosage form is easy to administer and doesn't need the help of a professional healthcare provider. In our study, the maximum score for rationality assessment was 14 (score of 6 and below was considered irrational whereas a score of 7 and above was considered rational). The risk was higher when the patient was administered with both salbutamol and thiazides or other potassium increasing antihypertensives.
Transient eosinophilia 12
Cefoperazone+Sulbactum;
The reaction is seen within 24 hours of administration and subsides with consequent administration. Increased liver enzymes 9 Lamivudine+Zidovudine+Nevirapine; Aspirin+Atorvastatin.
Pruritus 5
Guaifenesin+Terbutalin+Ambroxol; Chlorpheniramine+Codeine+Menthol. Parkinsonism 1 Amlodipine+Atenolol. 
Dextromethorphan+phenyleph rine+triprolidine
The risk or severity of adverse effects can be increased when triprolidine is combined with dextromethorphan. 5 Another reason is there is insufficient evidence that oral Phenylephrine is effective for OTC use as a decongestant. 6 Respiratory 45
Dextromethorphan+phenyleph rine+chlorpheniramine+guaife nesin
Guaifenesin which is an expectorant that helps to produce more productive cough so that it will get expelled through coughing reflex, but antitussive action of dextromethorphan inhibits the coughing by inhibiting the reflex, thus combining both will result in nullified action. 7
Respiratory 7
Chlorpheniramine+codeine Highly abused and lack of therapeutic justification. 8, 9 Respiratory 17
Aceclofenac+paracetamol
The strength of paracetamol as analgesic in FDC should be 325mg as per DCGI, but the FDC has usual dose of paracetamol which in synergism with aceclofenac is enough for liver failure. 10, 11 Musculoskeletal 0
Cetirizine+dextromethorphan +phenylephrine+menthol
The risk or severity of ADRs is increased when antihistaminic like cetrizine is combined with antitussive like dextromethorphan. Also there is insufficient evidence that oral phenylephrine is effective for OTC use as a decongestant. 6
Respiratory 7
The most common ADRs with the banned FDCs were drowsiness followed by irregular heart rate, though the combination of chlorpheniramine+codeine was also associated with pruritus and itching besides the drowsiness and increased heart rate. The risk of palpitations was high in cardiovascular patients receiving antihypertensive medicines. The majority of FDCs 95 (92.23%) were costlier than the sum of the cost of individual APIs and only 8 FDCs (7.77%) were cheaper than the sum of the cost of individual APIs. 
DISCUSSION
The most commonly prescribed FDCs belonged to the category of respiratory FDCs in all age groups except the age group between 68 to 77 years in which cardiovascular FDCs were commonly prescribed. The second most common class of FDCs was anti-infectives and alimentary FDCs in younger age groups while Cardiovascular and Alimentary in the geriatric population. The results were varying between different studies like in the study of Balasubramaniam et al, antibiotics were most commonly prescribed followed by antidiabetic FDCs. 12 Pradhan et al had multivitamins, Paudel et al had antimicrobials in PHC and SHC, THC had multivitamins, Manjunatha et al had alimentary FDCs most commonly prescribed followed by anti-infectives and blood and blood forming FDCs. [13] [14] [15] Whereas, Dhande et al had analgesics as most commonly prescribed followed by nutritional supplements. 16 The present study had a majority of rational FDCs (83.5%). Similar findings to the study done by Gupta et al showing 75% of rational FDCs. 18 On the other hand a study by Pradhan et al showed a majority of irrational FDCs (70%) possibly because the study included the nutraceutical supplements which have a wide range of components that may or may not have therapeutic justification. 13 Along with the study of Upadhyay et al, Nazmi et al also showed fewer rational FDCs than irrational, showing the percentage of 13.31% and 30%
respectively. The possible reason is that these studies are either prescription based or are done in the outpatient setting where chances of prescribing irrational FDCs are more due to less stringent rules and unawareness about FDCs. 1, 19 Oral dosage form was preferred over parenteral.
The finding is also supported by the studies of Pradhan et al, Balat et al and Dhande et al. 13, 16, 20 The present study had a majority of possible ADRs (62.53%), mild in terms of severity (71%). Likewise a study by Gor et al had 80% of possible ADRs with the majority being mild, as the rechallenge and dechallenge may not have occurred in the patients administering the non-steroidal anti-inflammatory drugs. 21 Different outcome in terms of causality assessment in the study done by Sudhakar et al showed majority of probable ADRs (85.2%); because even if it is not possible to actually perform rechallenge and dechallenge because of ethical concern, withdrawal of medicine after the occurrence of ADR and consequent decrease in ADR intensity can validate the probable causality assessment. 22 Differing in case of causality but similar in case of severity, the study done by Mukherjee et al had 83.03% probable/likely ADRs with majority ADRs being mild (83.33%). Because the study was done in case of antiretroviral medicines where there is no other option but to withdraw the drug when ADR occurs, and continue it upon the alleviation of ADR and so the majority of the ADRs fall under certain or probable causality. 23 Dual drug combinations were prominent in the present study constituting 85 FDCs, and rest were multidrug combinations; similar to the study done by Shende et al. 24 Also, 92.23% of FDCs were costlier than the sum of the cost of individual API. This was similar to the study by 
Cost analysis
Cheap Costly Nazmi et al stating 70% of FDCs were costlier. 19 However, FDCs were found to be cheaper in the study by Tahir et al. 25 
CONCLUSION
The present study highlights the greater use of FDCs in the tertiary care teaching hospital. Even though rational FDCs were found to be mostly prescribed in the study, the focus was on the banned FDCs which are still prescribed. Also, a similar study in the private setting has to be conducted to understand the pattern of FDCs used in a private setting.
